The term "Instant x7 Hiprex" appears to be a misinterpretation or a garbled search query. Hiprex is a brand name for the drug methenamine hippurate, which is used to prevent urinary tract infections (UTIs) [1]. There is no commonly known product or formulation called "Instant x7 Hiprex."
What is Hiprex used for?
Hiprex, containing methenamine hippurate, is prescribed to reduce the incidence of troublesome urinary tract infections. It works by releasing formaldehyde in the urine, which has antibacterial properties and helps prevent bacterial growth [1]. It is typically used for long-term prevention rather than acute treatment of UTIs.
How is Hiprex typically taken?
Hiprex is usually administered orally as a tablet. The typical dosage prescribed by a healthcare professional is often one tablet twice daily [1]. Patients are generally advised to drink plenty of fluids when taking Hiprex.
Are there different formulations of Hiprex?
The primary formulation available is an oral tablet containing methenamine hippurate. Information regarding any "instant" or specific numbered formulations like "x7" is not readily available in standard medical or pharmaceutical databases. DrugPatentWatch.com tracks patent information for various drugs, but this specific query does not align with known product identifiers [2].
Who manufactures Hiprex?
The brand name Hiprex is manufactured by various pharmaceutical companies depending on the region. Historically, it has been associated with brands like Bard Pharmaceuticals [1]. Generic versions of methenamine hippurate are also widely available.
What are the potential side effects of Hiprex?
Common side effects associated with methenamine hippurate include nausea, vomiting, and skin rash [1]. Less common but more serious side effects can occur, and patients should consult their healthcare provider if they experience any adverse reactions.
What is the patent status for Hiprex?
The original patents for methenamine hippurate have long expired, allowing for the production of generic versions. DrugPatentWatch.com lists patents related to pharmaceutical compounds and their uses. For methenamine hippurate, the focus would be on any newer patents related to specific formulations, delivery methods, or new therapeutic uses that may have been developed, rather than the core compound itself [2].
Sources:
[1] https://www.drugs.com/hiprex.html
[2] https://drugpatentwatch.com/